Drug Discovery

hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig

Shionogi partners with six Irish universities

  • Japan
  • |
  • News

Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for an R&D partnership with six Irish universities, under the company's Shionogi Science Programme. For now, the collaboration... Read more

sodium-tablets-generic

Daiichi Sankyo files NDA for Prasugrel in Japan


  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welfare... Read more

astars-genome-institute-of-singapore-gis-and-oxford-biodynamics-obd-will-use-episwitch-platform-to-differentiate-epigenetic-footprint-of-various-stem-cells-from-their-cell-lines

Prism to start PRI-724 trials to treat fibrosis


  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein... Read more

orexo-grants-astrazeneca-rights-to-conduct-trials-in-its-ox-cli-respiratory-program

AstraZeneca, Orexo to do respiratory drug trials

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel treatment of respiratory... Read more

good-news-for-chronic-iron-overload-patients-us-fda-approved-exjade-deferasirox

Exjade gets FDA nod for iron overload treatment

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older... Read more

ibn-develops-anti-microbial-hydrogel

IBM, A*Star co-develop anti-microbial hydrogel

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial... Read more

eye-disease

Aspirin use increases risk of age-related eye disease

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WMI), a close affiliate... Read more

approval-novartis

EU approves Novartis' Bexsero for meningitis

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) for use in individuals... Read more

Biotech-310x175_copy

Dong-A Pharma gets positive trial results for Evogliptin

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of DPP-4 inhibitor,... Read more

scientists-identify-protein-complex-responsible-for-gastrointestinal-cancers

Activation of mTorc1 causes colon, gastric cancers

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have identified a complex... Read more

novalix-and-kyowa-hakko-kirin-to-co-develop-novel-drug-candidates-against-protein-protein-interaction-targets

NovAliX, Kyowa Hakko Kirin sign deal

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko Kirin of Japan.... Read more

patrys-progresses-multiple-myeloma-clinical-trial-to-second-patient-group

Patrys gets nod to progress myeloma trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/IIa PAT-SM6 multiple... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X